Industry

EssilorLuxottica Opens Research and Development Center in Thailand, Will Serve as a ‘Strategic Hub’

Vision Monday12h ago1 min read

LAT KRABANG, Thailand—EssilorLuxottica (Euronext Paris: EL) has reached what it has identified as an important milestone in its innovation journey with the opening of a new research and development (R&D) center in Lat Krabang, Thailand, designed to accelerate how it develops, scales, and delivers the next generation of vision care solutions, wearables and medical technologies. Located near its major manufacturing facilities, the 5,000-square-meter center will serve as a strategic hub for ophthalmic lens materials and manufacturing technologies, the company advised, bringing together the entire value chain, from advanced materials research to industrial process development.

Read full article on Vision Monday

AI Summary

Quick Take

EssilorLuxottica has inaugurated a new 5,000-square-meter R&D center in Lat Krabang, Thailand, positioned as a strategic hub for ophthalmic lens materials and manufacturing technologies. The facility aims to accelerate the development and scaling of next-generation vision care solutions, including wearables and medical technologies, by integrating the entire value chain from research to industrial production.

Why It Matters

The opening of this center underscores a major industry shift toward co-locating research and manufacturing to shorten the innovation cycle. For eye care professionals, this means a likely acceleration in the availability of advanced lens materials and smart eyewear, as the company streamlines the transition from laboratory concepts to clinical products. This strategic investment in Thailand also highlights the region's growing importance as a global center for high-tech optical engineering and production efficiency.

Key Details

The 5,000-square-meter facility is located in Lat Krabang, Thailand, strategically situated near the company's major manufacturing plants.
The center will focus on the full value chain, bridging the gap between advanced materials research and industrial process development.
Key innovation targets include next-generation ophthalmic lens materials, manufacturing technologies, and vision care wearables.
The hub is designed to improve the speed and scale at which new medical technologies and vision solutions are delivered to the global market.

Who's Affected

Practice OwnersOptometristsOpticiansOptical Lab Managers

What's Next

As the center becomes fully operational, practitioners can expect a more robust pipeline of lens innovations and wearable technologies. The proximity to manufacturing suggests that new product launches may move from the R&D phase to the optical dispensary more rapidly than in previous cycles.

AI-generated summary — always read the original source for full context

Discussion

No comments yet. Be the first to share your thoughts.